Kindred Biosciences, Inc.
Variant Asparaginase Polypeptides for Medical Use
Last updated:
Abstract:
Provided are various embodiments relating to variant asparaginase polypeptides with enhanced stability, pharmacodynamics, and/or reduced immunogenicity. The variant asparaginase polypeptides may be used as therapeutics in mammals, including human, canines, felines, and equines.
Status:
Application
Type:
Utility
Filling date:
18 Apr 2019
Issue date:
4 Mar 2021